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SUMMARY: Age-related macular degeneration (AMD) is a medical condition of central loss vision and blind-
ness. Numerous studies have revealed that changes on certain dietary fatty acids (FAs) could have useful for 
AMD management. This review summarizes the effects of dietary omega-3 long-chain PUFAs, MUFAs, and 
SFAs, and lipoproteins on AMD. Findings are consistent with the beneficial role of dietary omega-3 long-chain 
PUFAs, while the effects of dietary MUFAs and SFAs appeared to be ambiguous with respect to the possible 
protection from MUFAs and to the possible adverse impact from SFAs on AMD. Some of the pathological 
mechanisms associated with lipoproteins on AMD share those observed previously in cardiovascular diseases. 
It was also noticed that the effects of FAs in the diet and lipoprotein on AMD could be modulated by genetic 
variants. From a population health perspective, the findings of this review are in favour of omega-3 long-chain 
FAs recommendations in a preventive and therapeutic regimen to attain lower AMD occurrence and progres-
sion rates. Additional long-term and short-term nutrigenomic studies are required to clearly establish the role 
and the relevance of interaction of dietary FAs, lipoproteins, and genes in the genesis and progression of AMD.
KEYWORDS: Age-related macular degeneration; Dietary fats; Fatty acids; Lipoproteins; Olive oil; Retina
RESUMEN: Efecto de los ácidos grasos y lipoproteínas de la dieta sobre la progresión de la degeneración 
macular relacionada con la edad. La degeneración macular asociada a la edad (DMAE) es una condición 
patológica caracterizada por pérdida de visión central y ceguera. Numerosos estudios han revelado que cier-
tos cambios en los ácidos grasos de la dieta podrían tener efectos beneficiosos en el manejo de la DMAE. En 
esta revisión se recogen los efectos de los ácidos grasos de la dieta poliinsaturados omega-3, monoinsaturados 
y saturados, y de las lipoproteínas en la DMAE. La literatura es consistente en el papel beneficioso de los 
ácidos grasos polinsaturados omega-3 de cadena larga, mientras que se muestra ambigua con los efectos de 
los ácidos grasos monoinsaturados y saturados de la dieta, respecto al posible papel protector de los ácidos 
grasos monoinsaturados como al posible efecto adverso de los ácidos grasos saturados en la DMAE. Además 
algunos mecanismos patológicos que asocian las lipoproteínas con la DMAE son los mismos observados 
previamente en las enfermedades cardiovasculares. Hacen falta estudios nutrigenómicos a corto y largo plazo 
para establecer el papel y la importancia de los ácidos grasos de la dieta, y las lipoproteínas en la aparición y 
progresión de la DMAE.
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1. INTRODUCTION
Age-related macular degeneration (AMD) was 
first described by Haab in 1888 (Haab, 1888), though 
Verhoeff and Grossman suggested that features of 
AMD might have been observed in 1875 (Verhoeff  
and Grosman, 1937). Nowadays, more than 2 mil-
lion people in United States of America are affected 
by AMD, the main cause of vision loss in adults 
(Saade and Smith, 2014). The two manifestations 
of AMD consist of “wet” AMD, exudative AMD, 
or choroidal neovascularization (CNV), and “dry” 
AMD or geographic atrophy (GA) (Jager et  al., 
2008). In the first states of AMD, most patients have 
drusen, lipid-rich deposits under the retinal pigment 
epithelium (RPE). The diffusion and growth of dru-
sen determine the detachment of RPE with a dam-
age of photoreceptors in the macula and subsequent 
vision loss. Dysfunction of the choroid, Bruch’s 
membrane, and the RPE are the principal mecha-
nisms involved in the onset of AMD (Lee et  al., 
2015). Environmental and genetic factors influence 
the events underlying the disease and modifying the 
individual risk factors of developing AMD (Ersoy 
et al., 2014). In line with this concept are the shared 
risk factors between AMD and cardiovascular dis-
ease (CVD), which suggests a mutual pathologi-
cal mechanism. Several researchers suggested that 
an atherosclerosis-like process might contribute 
to the formation of CVN, eventually leading to 
retinal dysfunction and the onset of AMD (Klein 
et al., 2007; Klein et al., 2013). In accordance with 
the importance of dietary fatty acids (FAs) and 
lipoproteins in CVD, previous studies have sought 
to underline their role on the fat metabolism as a 
risk factor for the onset of AMD. Taken the public 
health relevance of AMD, it is crucial the develop-
ment of effective prevention measures. It is con-
ceptually attractive that evaluating the influence of 
dietary FAs and lipoproteins on AMD could help to 
identify new targets for AMD management.
2.  STRUCTURE OF THE RETINA: A BRIEF 
DESCRIPTION
The sensory retina is arranged into layers of 
neurons. The light conversion into chemical signals 
happen in the outer segments of the cone (respon-
sible for colour vision and image-forming daylight) 
and rod (responsible for vision under low illumi-
nation) photoreceptors in the neural retina (Wang 
et al., 2014). Encoded retinal signals are integrated 
through visuals networks and finally cross to the 
optic nerve. Retinal blood vessels that arise from 
the central retinal artery supply the blood to the 
neural retina. Endothelial tight junctions control 
the transport through retinal blood vessels (inner 
blood–retinal barrier) (Promsote et al., 2014). The 
next monolayer is the RPE, which has pivotal roles 
in the integrity for homeostasis in the retina and the 
photoreceptor layer (Sonoda et al., 2009). Behind 
the RPE is the Bruch membrane, an elasto-collag-
enous and thick extracellular matrix. Together, the 
Bruch membrane and the RPE constitute the outer 
blood–retinal barrier, which protects the entrance 
of immune cells and macromolecules from the cho-
roid into the retinal layers. Located posterior to 
the Bruch membrane, the choroid has an intricate 
network of choriocapillaris, blood vessels that sup-
plies nutrients and oxygen to the optic nerve, outer 
retina, and RPE. The fenestrated choroidal endo-
thelium allows the transport of molecules to the 
RPE (Baltmr et al., 2014; Demeestere et al., 2015).
3.  AGE-RELATED MACULAR 
DEGENERATION
AMD is a growing retinal pathology characterized 
by the failure of vision as a direct result of damage 
into the macula. Despite the fact that the main causes 
of AMD are fully uncertain, a number of environmen-
tal and genetic risk factors have been linked with the 
AMD (Fritsche et al., 2013). Moreover, factors such 
as gender, race, advanced age, and smoking are well 
recognized to substantially increase the risk of AMD. 
Factors such as hypertension, obesity, and malnutri-
tion (e.g. high intake of cholesterol and dietary fats 
or low intake of dietary vitamin D, zinc, and anti-
oxidants) may also play a role in the pathogenesis 
of AMD (Clemons et al., 2005; Dasari et al., 2011; 
Millen et al., 2015; Parekh et al., 2009; Sui et al., 2013). 
Furthermore, AMD has been recently associated with 
retinal low-grade inflammation linked by the infiltra-
tion and activation of immune cells and production of 
inflammatory mediators into the site of retinal dam-
age (Nita et al., 2014; Whitcup et al., 2013).
The deposition of drusen between the choroid 
and the RPE is the main early hallmark of AMD 
onset. Drusen are constituted by glycoprotein vitro-
nectin, apolipoprotein E (ApoE), ApoJ (clusterin), 
amyloid P component, albumin, coagulation fac-
tor X, Alzheimer’s Aβ-peptide, and tissue inhibi-
tor of metalloproteinases 3 (Johnson et al., 2002; 
Mullins et al., 2000). Interestingly, these compo-
nents are unspecific to drusen, and are usual into 
extracellular deposits related with other disorders, 
such as atherosclerosis and other CVD (Mullins et 
al., 2000). Moreover, over 40% of drusen have lipid 
components, mainly phosphatidylcholine and cho-
lesterol (Wang et al., 2010). In agreement with the 
hypothesis that oxidative stress promotes to AMD 
pathology, compounds of lipid oxidation are highly 
abundant in AMD drusen (Chiras et al., 2015).
Advanced AMD exists in two clinical manifes-
tations: neovascular and non-neovascular AMD 
(Pascolini and Mariotti, 2012). CNV, involving 
aberrant growth of immature chroroidal blood ves-
sels through the outer blood-retinal barrier, is the 
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hallmark of neovascular AMD, also termed as 
exudative or “wet” AMD. Due to the formation of 
newly choroidal blood vessels, the sub-retinal space 
is exposed to blood components. Thus, in this mani-
festation of AMD are also detected sub-retinal fluid 
accumulation, lipid deposition, haemorrhage, RPE 
detachment, and fibrotic scar. Importantly, while 
neovascular AMD only affect to 10%–15% of AMD 
patients, this manifestation may progress rapidly 
and lead the most severe vision loss (Celkova et al., 
2015). In addition, GA within the macula, implying 
a cell death and thereby a diminution of functional 
RPE and photoreceptors, is the hallmark of non-
neovascular, non-exudative or “dry” AMD.
The World Health Organization (WHO) estimates 
that worldwide, 285 million people representing 
about 4% of the total population may be currently 
affected by some form of visual disability, including 
AMD as one of the main clinical issues in developed 
countries (Pascolini and Mariotti, 2012). It has been 
recently reported that the global prevalence of AMD 
may reach 8.7% of people after the age of 45 years 
(Rassoulinejad et al., 2015). The problem is being 
worse in Europe, because about 18% of all people 45 
years of age or over is likely afflicted from one of the 
two clinical manifestations of AMD. In people aged 
between 70–79 years, the prevalence of AMD may 
reach 32%, increasing to 45% in people over 80 years. 
These observations suggest that nearly one in two 
people develop AMD at elderly age. It is expected 
that this will happen in 59 millions Europeans by 
2020 and in 70 millions by 2040 (Wong et al., 2014).
4.  DIETARY FATTY ACIDS IN AGE-RELATED 
MACULAR DEGENERATION
Several studies have attempted to elucidate the 
effects of dietary habits on susceptibility to AMD. The 
risk for AMD has been shown to increase in individu-
als ingesting lower amount of certain nutrients than in 
individuals ingesting higher amounts. This is the case 
for the intake of omega-3 long-chain polyunsaturated 
fatty acids (PUFAs), particularly docosahexaenoic 
acid (DHA), carotenoids lutein and zeaxanthin, and 
zinc (Weikel et al., 2012a). However, these observa-
tions can be dramatically affected by differences in 
various aspects of study design, including populations 
and classification systems used. Dietary patterns have 
also an effect on risk for AMD. For example, indi-
viduals who consume diets with a high glycemic index 
(GI) are more prone to developing AMD (Weikel et 
al., 2012b). In contrast, lower GI diets are protective 
against AMD, most notably against early signs of dis-
ease. Western-type diets, which typically contain more 
red and processed meats, high-fat dairy products, and 
refined grains also increase the risk for AMD when 
compared to diets rich in vegetables, fruits, legumes, 
seafoods, and whole grains (Chiu et al., 2014). It is note-
worthy that several efforts have been made in defining 
the relationship between dietary fat intake and AMD. 
Fats are composed of FAs, which are carboxylic acids 
that often have long unbranched aliphatic chains. 
Based on their structural and chemical properties, 
FAs can be classified as saturated fatty acids (SFAs), 
monounsaturated fatty acids (MUFAs), and PUFAs. 
The major dietary FAs are palmitic acid (16:0), stearic 
acid (18:0), oleic acid (18:1n-9), linoleic acid (18:2n-
6), dihomo-γ-linolenic acid (20:3n-6), α-linolenic acid 
(18:3n-3), eicosapentaenoic acid (EPA, 20:5n-3), and 
DHA (22:6n-3) (López et al., 2014). The chemical 
structures of principal FAs in retina are displayed in 
Table 1.
The needs of omega-3 long-chain PUFAs in 
patients with AMD is supported due to the fact 
that DHA accounts for 50–60% of the total FA 
content of photoreceptor outer segments, which are 
constantly replenishing. This process makes nec-
essary an extraordinary input on dietary DHA or 
its precursors, since a deficiency of such FAs may 
predispose to the development of AMD (Evans and 
Lawrenson, 2014). Furthermore, omega-3 long-
chain PUFAs play a role against oxidative stress, 
inflammation, and vascular dysfunction, which 
are closely associated to the pathogenesis of AMD 
(Bjelakovic et al., 2012; Kishan et al., 2011). There is 
evidence of a link between the consumption of cold-
water fatty fish rich in omega-3 long-chain PUFAs 
and the reduction in the risk of developing AMD 
(Chong et al., 2009; Christen et al., 2011; Omenn, 
2007; SanGiovanni and Chew, 2005). Similarly, indi-
viduals with moderate to high risk of progression to 
late-stage AMD under-reporting high consumption 
of omega-3 long-chain PUFAs had a 30% lower inci-
dence rate of neovascular AMD comparing to those 
individuals who reported a low dietary consump-
tion of such FAs (Tan et al., 2009). The administra-
tion of a daily dose of EPA (350 mg) and DHA (650 
mg) for 3 years has been shown to lower the risk of 
CNV in patients with early lesions of AMD, steadily 
achieving the highest tertile of omega-3 long-chain 
PUFAs in their red blood cell membranes (Souied 
et al., 2013). As long-term biomarkers of omega-3 
long-chain PUFAs (Gorusupudi et al., 2016), red 
blood cell membranes with increased content of 
EPA and DHA (and plasma EPA) after dietary 
intake of seafoods are associated with a lower risk 
for neovascular AMD (Merle et al., 2014). The 
combination of omega-3 long-chain PUFAs with 
intravitreal anti-vascular endothelial growth factor 
(VEGF) treatment also decreases vitreous VEGF-A 
levels in patients with AMD (Rezende et al., 2014). 
However, if  co-ingested with the Age-Related Eye 
Disease Study (AREDS) formulation (antioxidant 
vitamins C and E, beta carotene, and zinc), a daily 
dose of EPA (350 mg) and DHA (650 mg) for a 
period of time up to 5 years in people at high risk 
for progression to advanced AMD was reported not 
to offer an additional advantage in reducing the risk 
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of developing advanced AMD (Age-Related Eye 
Disease Study 2 Research Group et al., 2013). A sys-
tematic review of nine studies, with a total sample of 
88974 people that included 3203 AMD cases (1847 
with early AMD and 1356 with late AMD), exam-
ining the link between fat consumption and AMD 
was reported by Chong et al. (2008). In this meta-
analysis, not only a high dietary intake of omega-3 
long-chain PUFAs was associated with a reduction 
(38%) in the risk for late AMD, but also the risk for 
both early and late AMD was diminished with only 
bi-weekly fish intake. While the authors concluded 
that dietary omega-3 long-chain PUFAs could be 
responsible for the lower rates of AMD progres-
sion, evidence-based dietary recommendations for 
consumption of omega-3 long-chain PUFAs among 
general population in AMD prevention require fur-
ther research. An issue that deserves exploration is 
related with the relevance of interactions between 
environmental and genetic factors in the develop-
ment and progression of AMD (Lim et al., 2012). 
As the major AMD-susceptibility genetic factor, 
accounting for approximately 30%–50% of AMD 
patients, the complement factor H (CFH) gene has 
been proposed to interact with lipid metabolism to 
affect AMD risk (Neale et al., 2010). Thus, while 
DHA (840 mg/day over 3 years) has been recently 
shown to exert protective effects against the occur-
rence of CNV in genetically non-risk patients with 
early lesions of AMD, a genetic predisposition to 
AMD conferred by the CFH Y402H (rs1061170) 
variant may limit these benefits of DHA supple-
mentation (Wang et al., 2015). It is plausible that 
inconsistencies in estimating the benefits of omega-3 
long-chain PUFAs on AMD are due in part to have 
missed the genetic component of the disease.
In the Melbourne Collaborative Cohort Study 
(Chong et al., 2009), higher intake of olive oil was 
reported to be inversely associated with late AMD. 
However, despite olive oil contains large amounts 
of oleic acid, it was unclear the contribution of 
MUFAs to this association. It is critical to contex-
tualize the potential effects of dietary FAs for a 
number of retinal disorders, as MUFAs from beef, 
dairy fats, and partially hydrogenated vegetable oils, 
without additional adjustment for the intake of other 
fats, were associated with a higher risk for AMD in 
the Eye Disease Case Control Study (Seddon et al., 
2001). No association of AMD progression with the 
intake of SFAs, MUFAs, omega-6 PUFAs or trans 
FAs was observed in the Cardiovascular Health and 
Age-Related Maculopathy Study (Robman et al., 
2007) and in the Polanut Study (Delcourt et al., 2007). 
Solid vegetable fats containing omega-6 PUFAs were 
shown to have a direct association with AMD in 
the Carotenoids in Age-Related Eye Disease Study 
(Parekh et al., 2009), while MUFAs had protective 
effects. The first evidence of a potential effect of SFAs 
against AMD was provided by Mares-Perlman et al. 
(1995) who found an increased risk for early AMD 
in individuals with the highest intake of SFAs and 
cholesterol. More recent studies have also reported 
Table 1. Chemical structures and food sources of the major fatty acids in human retinal membranes
Fatty acid (%) (Acar et al., 2012) Food sources
16:0, palmitic acid (21%)
Palm oil, cotton oil, butter, chicken fat
18:0, stearic acid (20%)
Chocolate, butter, sesame oil, blood sausage, cookie, palm oil
18:1n−9, oleic acid (14%)
Olive oil, rapeseed oil, hazelnut, corn margarine, sesame oil, 
peanut oil
20:4n−6, arachidonic acid (11%)
Pork, veal, lamb, deer, chicken, beef
20:5n−3, EPA (2%)
Herring, mussel, salmon, trout, mullet, gilt-head bream
22:6n−3, DHA (15%)
Herring, swordfish, trout, salmon, albacore, mackerel
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similar results on dietary SFAs and the risk for AMD 
(Cho et al., 2001; Seddon et al., 2003; Smith et al., 
2000). In line with this notion, the interaction of 
exogenous FAs, supplied into triglyceride-rich lipo-
proteins, with RPE cells causes pathogenic effects in 
a fatty acid-dependent manner, being MUFAs and 
omega-3 long-chain PUFAs much less harmful than 
SFAs (Montserrat-de la Paz et al., 2016).
5.  LIPOPROTEINS IN AGE-RELATED 
MACULAR DEGENERATION
The retina has been shown to uptake circulat-
ing low-density lipoproteins (LDL) through the 
RPE and Müller cells (Bretillon et al., 2012). In this 
process, which is mediated by LDL receptors, neu-
rons are provided with lipids to the maintenance or 
renewal of retinal ganglion cell axons and photore-
ceptor outer segments (DiBattista et al., 2015). In the 
same sense, this shuttle involves high-density lipo-
proteins (HDL). ABCA1 transporter and SR-BI and 
SR-BII receptors are constitutively expressed in RPE 
cells (Ananth et al., 2014). The ABCA1 transporter 
participates in apoE- and apoA1-dependent HDL 
biogenesis, whereas HDL uptake is mediated by scav-
enger receptors (SR-BI and SR-BII). Some correla-
tions between AMD and HDL metabolism have been 
studied. For example, when transgenic mice express-
ing a dysfunctional form of human apoE3 (modelling 
human type III hyperlipoproteinemia) were subjected 
to a high-fat diet for a period of 9 months, all of them 
exhibited lipid deposits reactive for human apoE in 
the retina of both eyes. However, this abnormal-
ity was observed in only 33% of animals subjected 
to a normal diet or was absent in mice lacking apoE 
subjected to either diet. It is suggestive of a role for 
dysfunctional apoE in AMD development (Kliffen 
et al., 2000). The major single nucleotide polymor-
phisms (SNPs) involved in HDL metabolism, the 
cholesteryl ester transfer protein (CETP) rs3764261, 
the lipoprotein lipase (LPL) rs12678919, and the 
hepatic lipase (LIPC) rs10468017 variants have been 
linked to AMD in a genome-wide association study 
(Merle et al., 2015). After adjusting for the CFH 
gene, the CETP rs3764261 and LPL rs12678919 vari-
ants were found to be positively related to the risk of 
AMD, whereas the LIPC rs10468017 variant might 
be involved in a reduction of susceptibility to AMD 
(Haines et al., 2005). These observations indicate 
potential interactions of diet, lipoprotein metabolism, 
and genes in the complement system linked to AMD. 
The metabolism of LDL, as a principal apoB100-
containing lipoprotein, has been also involved in the 
pathogenesis of AMD. Mice expressing functional 
human apoB100 are more susceptible to lipid accu-
mulation in sub-RPE deposits upon photo-oxidative 
stress and after a high-fat diet, a result alleviated by 
vitamin E pre-treatment (Espinosa-Heidmann et al., 
2004; Fujihara et al., 2009). Increased secretion of 
apoB100-rich lipoproteins by RPE cells has been 
proposed as a mechanism for prevention of cell death 
through lipotoxicity. Sub-RPE lipid deposits are 
involved in the pathogenesis of AMD (Curcio et al., 
2009). Furthermore, a high-fat diet also promoted the 
occurrence of thickening, membrane-bound translu-
cent particles, and immunolocalization of VEGF in 
Brunch’s membrane of LDLR-/- mice, supporting the 
notion of accelerated AMD under decreased LDL 
clearance (Rudolf et al., 2005). These studies suggest-
ing that lipoprotein accumulation in RPE, synergistic 
with hyperlipidaemia and associated with a high-fat 
diet, is related to AMD pathogenesis.
6. CONCLUSIONS
The progression of AMD has social and economic 
implications. Due to the burden of this disease, efforts 
have been made to identify strategies that can delay 
the onset or progression of AMD. A growing body 
of evidence suggests that the dietary fatty acids and 
lipoproteins play a pivotal, yet underappreciated, role 
in the genesis and progression of AMD.
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